William Blair & Company’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.1M | Buy |
43,593
+39,212
| +895% | +$1.83M | 0.01% | 724 |
|
|
2025
Q4 | $212K | Sell |
4,381
-48
| -1% | -$2.38K | ﹤0.01% | 1438 |
|
|
2025
Q3 | $209K | Buy |
+4,429
| New | +$214K | ﹤0.01% | 1451 |
|
|
2025
Q2 | – | Sell |
-4,427
| Closed | -$246K | – | 1894 |
|
|
2025
Q1 | $246K | Buy |
+4,427
| New | +$240K | ﹤0.01% | 1320 |
|
|
2024
Q4 | – | Sell |
-3,769
| Closed | -$217K | – | 1881 |
|
|
2024
Q3 | $217K | Buy |
+3,769
| New | +$203K | ﹤0.01% | 1408 |
|
|
2024
Q2 | – | Sell |
-4,205
| Closed | -$204K | – | 1878 |
|
|
2024
Q1 | $204K | Buy |
+4,205
| New | +$205K | ﹤0.01% | 1398 |
|
|
2023
Q3 | – | Sell |
-18,149
| Closed | -$978K | – | 1845 |
|
|
2023
Q2 | $978K | Buy |
18,149
+615
| +4% | +$33.1K | ﹤0.01% | 850 |
|
|
2023
Q1 | $954K | Buy |
17,534
+1,233
| +8% | +$60K | ﹤0.01% | 846 |
|
|
2022
Q4 | $789K | Sell |
16,301
-277
| -2% | -$12.2K | ﹤0.01% | 908 |
|
|
2022
Q3 | $630K | Buy |
16,578
+7,486
| +82% | +$334K | ﹤0.01% | 970 |
|
|
2022
Q2 | $455K | Buy |
+9,092
| New | +$483K | ﹤0.01% | 1098 |
|
|
2022
Q1 | – | Sell |
-4,722
| Closed | -$237K | – | 1996 |
|
|
2021
Q4 | $237K | Buy |
+4,722
| New | +$234K | ﹤0.01% | 1503 |
|
|
2021
Q3 | – | Sell |
-4,982
| Closed | -$262K | – | 1934 |
|
|
2021
Q2 | $262K | Sell |
4,982
-701
| -12% | -$36.6K | ﹤0.01% | 1400 |
|
|
2021
Q1 | $281K | Buy |
5,683
+916
| +19% | +$44K | ﹤0.01% | 1351 |
|
|
2020
Q4 | $232K | Sell |
4,767
-121
| -2% | -$5.97K | ﹤0.01% | 1366 |
|
|
2020
Q3 | $245K | Buy |
+4,888
| New | +$252K | ﹤0.01% | 1213 |
|
|
2020
Q1 | – | Sell |
-3,052
| Closed | -$153K | – | 1758 |
|
|
2019
Q4 | $153K | Buy |
3,052
+134
| +5% | +$6.28K | ﹤0.01% | 1349 |
|
|
2019
Q3 | $135K | Buy |
2,918
+817
| +39% | +$35.2K | ﹤0.01% | 1346 |
|
|
2019
Q2 | $91K | Sell |
2,101
-3,678
| -64% | -$156K | ﹤0.01% | 1435 |
|
|
2019
Q1 | $256K | Sell |
5,779
-272
| -4% | -$11.7K | ﹤0.01% | 1204 |
|
|
2018
Q4 | $263K | Sell |
6,051
-458
| -7% | -$20.2K | ﹤0.01% | 1132 |
|
|
2018
Q3 | $291K | Hold |
6,509
| – | – | ﹤0.01% | 1152 |
|
|
2018
Q2 | $260K | Sell |
6,509
-3,672
| -36% | -$145K | ﹤0.01% | 1178 |
|
|
2018
Q1 | $408K | Sell |
10,181
-8,863
| -47% | -$369K | ﹤0.01% | 987 |
|
|
2017
Q4 | $819K | Sell |
19,044
-4,429
| -19% | -$204K | 0.01% | 800 |
|
|
2017
Q3 | $1.17M | Buy |
23,473
+4,649
| +25% | +$225K | 0.01% | 685 |
|
|
2017
Q2 | $902K | Buy |
18,824
+5,635
| +43% | +$269K | 0.01% | 786 |
|
|
2017
Q1 | $570K | Buy |
13,189
+5,010
| +61% | +$213K | ﹤0.01% | 868 |
|
|
2016
Q4 | $331K | Sell |
8,179
-1,603
| -16% | -$63.2K | ﹤0.01% | 957 |
|
|
2016
Q3 | $374K | Buy |
9,782
+34
| +0.3% | +$1.36K | ﹤0.01% | 936 |
|
|
2016
Q2 | $408K | Sell |
9,748
-707
| -7% | -$29K | ﹤0.01% | 871 |
|
|
2016
Q1 | $420K | Sell |
10,455
-373
| -3% | -$15K | ﹤0.01% | 839 |
|
|
2015
Q4 | $461K | Sell |
10,828
-391
| -3% | -$18K | ﹤0.01% | 824 |
|
|
2015
Q3 | $532K | Sell |
11,219
-290
| -3% | -$14.8K | ﹤0.01% | 954 |
|
|
2015
Q2 | $570K | Buy |
11,509
+142
| +1% | +$7.2K | ﹤0.01% | 1718 |
|
|
2015
Q1 | $561K | Sell |
11,367
-35,403
| -76% | -$1.69M | ﹤0.01% | 1690 |
|
|
2014
Q4 | $2.13M | Sell |
46,770
-736
| -2% | -$35.7K | ﹤0.01% | 1266 |
|
|
2014
Q3 | $2.68M | Buy |
47,506
+35,987
| +312% | +$1.93M | ﹤0.01% | 1178 |
|
|
2014
Q2 | $612K | Sell |
11,519
-2,083
| -15% | -$111K | ﹤0.01% | 1607 |
|
|
2014
Q1 | $710K | Sell |
13,602
-26,342
| -66% | -$1.33M | ﹤0.01% | 1517 |
|
|
2013
Q4 | $2.14M | Sell |
39,944
-6,257
| -14% | -$323K | ﹤0.01% | 1156 |
|
|
2013
Q3 | $2.34M | Sell |
46,201
-2,792
| -6% | -$142K | ﹤0.01% | 1084 |
|
|
2013
Q2 | $2.52M | Buy |
+48,993
| New | +$2.61M | 0.01% | 1014 |
|
Other funds holding SNY
MIP
William Blair & Company's SNY Position: Q1 2026 in Review
William Blair & Company increased its Sanofi (SNY) stake by 895% in Q1 2026, buying an estimated $1.83M and bringing the position to 43,593 shares worth $2.1M. The position accounts for 0.01% of the portfolio, ranked #724.
William Blair & Company first reported a position in SNY in Q2 2013 and has held it in 43 quarters since. The position peaked at $2.68M in Q3 2014. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.
- William Blair & Company held 43,593 shares of Sanofi worth $2.1M as of Q1 2026.
- William Blair & Company bought 39,212 Sanofi shares in Q1 2026, an estimated $1.83M.
- Sanofi made up 0.01% of William Blair & Company's portfolio in Q1 2026, its #724 holding.
- William Blair & Company first reported a position in Sanofi in Q2 2013 and has held it in 43 quarters since.
- William Blair & Company's Sanofi position peaked at $2.68M in Q3 2014.
- 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.